These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 5055709

  • 1. Urinary hydroxyproline excretion in carcinoma of the breast.
    Cuschieri A, Felgate RA.
    Br J Exp Pathol; 1972 Jun; 53(3):237-41. PubMed ID: 5055709
    [Abstract] [Full Text] [Related]

  • 2. [Hydroxyproline in the diagnosis of bone metastases in breast cancer].
    Gasser AB, Depierre D, Alberto P, Courvoisier B.
    Schweiz Med Wochenschr; 1977 Jul 16; 107(28):984-6. PubMed ID: 897640
    [Abstract] [Full Text] [Related]

  • 3. Urinary hydroxyproline excretion in patients with cancer.
    Guzzo CE, Pachas WN, Pinals RS, Krant MJ.
    Cancer; 1969 Aug 16; 24(2):382-7. PubMed ID: 5796782
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Urinary hydroxyproline excretion before and after hypophysectomy in patients with bone metastases from breast cancer].
    Ditzel J, Jordal R, Riskoer N.
    Ugeskr Laeger; 1968 Oct 17; 130(42):1766-71. PubMed ID: 5724711
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hydroxyproline excretion in patients with breast cancer and response to treatment.
    Powles TJ, Leese CL, Bondy PK.
    Br Med J; 1975 Apr 26; 2(5964):164-6. PubMed ID: 1125725
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Circadian rhythm of total urinary hydroxyproline excretion and 3-H hydroxyproline test.
    Radom S, Zulawski M, Dahlig E.
    Clin Chim Acta; 1972 Jun 26; 39(1):277-8. PubMed ID: 4556834
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The hypronosticon test in breast cancer.
    Roberts JG, Williams M, Henk JM, Bligh AS, Baum M.
    Clin Oncol; 1975 Mar 26; 1(1):33-43. PubMed ID: 1204270
    [No Abstract] [Full Text] [Related]

  • 17. Three-centre study on urinary hydroxyproline excretion in cancer of the breast.
    Cuschieri A, Jarvie R, Taylor WH, Cant E, Furnival CM, Blumgart LH.
    Br J Cancer; 1978 Jun 26; 37(6):1002-5. PubMed ID: 678421
    [Abstract] [Full Text] [Related]

  • 18. Postabsorptive urinary hydroxyproline test in patients with metastatic bone disease from breast cancer.
    Niell HB, Palmieri GM, Neely CL, McDonald MW.
    Arch Intern Med; 1981 Oct 26; 141(11):1471-3. PubMed ID: 7283558
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Urinary hydroxyproline in the management of breast cancer.
    Cuschieri A.
    World J Surg; 1977 May 26; 1(3):299-302. PubMed ID: 883324
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.